TY - JOUR
T1 - Radical cations in the horseradish peroxidase and prostaglandin H synthase mediated metabolism and binding of benzo[a]pyrene to deoxyribonucleic acid
AU - Cavalieri, Ercole L.
AU - Devanesan, Prabhakar D.
AU - Rogan, Eleanor G.
N1 - Funding Information:
* Supported by U.S. Public Health Service Grants CA25176 and CA36727 from the National Cancer Institute. t To whom correspondence should be addressed: The Eppley Institute for Research in Cancer, University of Nebraska Medical Center, 42nd and Dewey Ave., Omaha, NE 68105. $ Abbreviations: BP, benzo[a]pyrene; 6-FBP, 6-fluorobenzo[a]pyrene; PAH, polycyclic aromatic hydrocarbons; HRP, horseradish peroxidase; and PHS, prostaglandin H synthase.
PY - 1988/6/1
Y1 - 1988/6/1
N2 - Metabolism and DNA binding studies are used to investigate mechanisms of activation for carcinogens. In this paper we describe metabolism of benzo[a]pyrene (BP) and 6-fluorobenzoa]pyrene (6-FBP) by two peroxidases, horseradish peroxidase (HRP) and prostaglandin H synthase (PHS), which are known to catalyze one-electron oxidation. In addition, binding of BP and BP quinones to DNA was compared in the two enzyme systems. The only metabolites formed from BP or 6-FBP by either enzyme were the quinones, BP 1,6-, 3,6- and 6,12-dione. HRP metabolized BP and 6-FBP to the same extent and produced the same proportion of each dione from both compounds, approximately 40% each of BP 1,6- and 3,6-dione and 20% BP 6,12-dione. PHS formed twice as much quinones from BP as from 6-FBP and produced relatively more BP 3,6-dione from 6-FBP (46%) compared to BP (30%) and relatively less BP 6,12-dione from 6-FBP (16%) compared to BP (33%). Removal of the fluoro substituent in the metabolism of 6-FBP is consistent only with an initial one-electron oxidation of the substrate. Since BP quinones were the only products formed in HRP- and PHS-catalyzed activation of BP, their possible binding to DNA was compared to that of BP. No significant binding of BP quinones to DNA occurred with either HRP or PHS. These results, coupled with those from other chemical and biochemical experiments, demonstrate that HRP- and PHS-catalyzed one-electron oxidation of BP to its radical cation is the mechanism of formation of quinones and binding of BP to DNA.
AB - Metabolism and DNA binding studies are used to investigate mechanisms of activation for carcinogens. In this paper we describe metabolism of benzo[a]pyrene (BP) and 6-fluorobenzoa]pyrene (6-FBP) by two peroxidases, horseradish peroxidase (HRP) and prostaglandin H synthase (PHS), which are known to catalyze one-electron oxidation. In addition, binding of BP and BP quinones to DNA was compared in the two enzyme systems. The only metabolites formed from BP or 6-FBP by either enzyme were the quinones, BP 1,6-, 3,6- and 6,12-dione. HRP metabolized BP and 6-FBP to the same extent and produced the same proportion of each dione from both compounds, approximately 40% each of BP 1,6- and 3,6-dione and 20% BP 6,12-dione. PHS formed twice as much quinones from BP as from 6-FBP and produced relatively more BP 3,6-dione from 6-FBP (46%) compared to BP (30%) and relatively less BP 6,12-dione from 6-FBP (16%) compared to BP (33%). Removal of the fluoro substituent in the metabolism of 6-FBP is consistent only with an initial one-electron oxidation of the substrate. Since BP quinones were the only products formed in HRP- and PHS-catalyzed activation of BP, their possible binding to DNA was compared to that of BP. No significant binding of BP quinones to DNA occurred with either HRP or PHS. These results, coupled with those from other chemical and biochemical experiments, demonstrate that HRP- and PHS-catalyzed one-electron oxidation of BP to its radical cation is the mechanism of formation of quinones and binding of BP to DNA.
UR - http://www.scopus.com/inward/record.url?scp=0023927397&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0023927397&partnerID=8YFLogxK
U2 - 10.1016/0006-2952(88)90579-5
DO - 10.1016/0006-2952(88)90579-5
M3 - Article
C2 - 3132173
AN - SCOPUS:0023927397
SN - 0006-2952
VL - 37
SP - 2183
EP - 2187
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 11
ER -